Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

Keratin 40 Inhibitors

Keratin 40 (KRT40) is a constituent of the keratin family, which is renowned for their filament-forming capabilities and fundamental roles in the structural integrity of epithelial cells. The extensive keratin family is typified by a heterogeneous assortment of proteins, each contributing to the mechanical resilience and protective attributes of epithelial tissues. Embedded within this multifaceted protein family, KRT40 has been identified as one of the hair-specific keratins. The proper assembly and maintenance of keratins are pivotal for safeguarding epithelial cells from various forms of environmental and mechanical stress. Given the profound importance of keratins, including KRT40, in upholding tissue integrity and function, disruptions or aberrations in their expression or assembly can result in a cascade of cellular perturbations, culminating in compromised cellular function. The class of compounds dubbed KRT40 inhibitors encompasses a broad spectrum of molecules posited to modulate the synthesis, assembly, or function of the KRT40 protein. These inhibitors generally operate through a myriad of mechanisms to exert their modulatory effects. Some are speculated to interfere with the transcriptional or translational machinery, thus reducing the synthesis of KRT40. Others might target the post-translational modifications of KRT40, including phosphorylation, affecting its assembly and interaction with other cellular components. A different subset might target the pathways that influence the overall keratin dynamics, thereby indirectly impinging upon KRT40's cellular activity. Despite the variation in their modes of action, these inhibitors are unified by their overarching objective: to influence the presence, assembly, or function of KRT40 within cells. As with any class of biochemical modulators, the precise and nuanced effects of these inhibitors warrant rigorous scientific inquiry to delineate their specificities and potential off-target effects.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor that might prevent stress-induced phosphorylation of KRT40, preserving its native state or interactions.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

p38 MAPK inhibitor that could impact changes in KRT40 phosphorylation state and functionality.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$92.00
$223.00
30
(1)

As an inhibitor of the Src family kinase, PP2 might affect KRT40 by altering kinase-mediated processes.

Withaferin A

5119-48-2sc-200381
sc-200381A
sc-200381B
sc-200381C
1 mg
10 mg
100 mg
1 g
$127.00
$572.00
$4090.00
$20104.00
20
(1)

Might bind or influence KRT40 in a similar manner to its effect on vimentin, potentially affecting its structure or function.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

Inhibits protein synthesis, which could reduce newly synthesized KRT40 in cells.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Inhibits RNA synthesis; potentially reduces KRT40 mRNA and protein levels.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

MEK inhibitor that might influence KRT40 expression or phosphorylation.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$80.00
$212.00
$408.00
48
(1)

TGF-beta inhibitor that may alter keratin expression patterns, including KRT40.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

PI3K inhibitor that might indirectly influence KRT40 synthesis, assembly, or degradation.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

HDAC inhibitor that might indirectly influence KRT40 transcriptional levels and protein abundance.